Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Health Strategies

Dáil Éireann Debate, Tuesday - 20 June 2017

Tuesday, 20 June 2017

Ceisteanna (1536)

Louise O'Reilly

Ceist:

1536. Deputy Louise O'Reilly asked the Minister for Health the status of recommendation 8.7 of the national cardiovascular health policy 2010-2019 on the establishment of a national group representative of stakeholders to determine priorities for research and health technology in cardiovascular care; the frequency with which this group has met since the publication of the policy; the outcomes and recommendations from this group, in addition to current projects; and if he will make a statement on the matter. [28791/17]

Amharc ar fhreagra

Freagraí scríofa

The Health Research Board, in line with the recommendation, coordinates the priorities for research in conjunction with key stakeholders such as academics, service providers and policy makers.

In relation to the research being carried out in conjunction with the Health Research Board, the Board has supported a number of awards conducting research into cardiovascular health. Cardiovascular health research is supported through a wide variety of funding instruments ranging from Summer Student projects, Investigator Led Projects through to a Stroke Clinical Trials Network awarded in 2014 to support the conduct of multi-centre clinical trials.

Examples of cardiovascular research include:

- In 2012 we supported Professor Rose Ann Kenny with an ICE Award entitled “Effecting change in cardiovascular health of older Irish adults: rapid translation of cardiovascular health research findings into policy and practice in a recession”;

- In 2011 we supported Dr Andrew Smyth with a NSAFP award entitled “Sodium and Potassium Intake and Risk of Cardiovascular and Chronic Kidney Disease”.

This is complemented by other types of assessment such as health technology assessment (HTA). In 2014 the Government granted approval for the Health Information and Quality Authority (HIQA) to undertake a HTA of a public access defibrillation programme (PAD) for Ireland because there were a number of questions that needed consideration before designing a public access defibrillation programme. Following a Public Consultation in October 2014, the HIQA Board approved a Report and set of recommendations for the Minister. The Health Technology Assessment (HTA) examined the implication of establishing a national public access defibrillation (PAD) programme in Ireland to increase survival from out-of-hospital cardiac arrest (OHCA). It estimated the clinical and cost effectiveness of a range of PAD configurations.

Barr
Roinn